Novel cancer therapies targeting angiogenesis

Monte Willis, Nancy Klauber-DeMore

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Cancer growth is generally restricted to tissue that is approximately 2 mm in diameter. At this size, the cancer receives enough oxygen and nutrients by diffusion from nearby blood vessels to survive. Upon further growth, the proliferation of cells within the cancer is matched by the induction of apoptosis due to nutrient deprivation, resulting in a steady-state size. The way cancers adapt to these physical limits is by obtaining their own new blood supply. Only through the induction of its own blood supply, generally by the process of angiogenesis, can cancers exceed the 2 mm size limit and can continue to grow virtually unchecked. Cancer cells stimulate angiogenesis by secreting soluble factors that stimulate vessel growth and/or by suppressing factors that prevent angiogenesis. These factors act primarily upon endothelial cells to promote their proliferation and migration, resulting in the sprouting and formation of tubes, which then develop into vessels.

Original languageEnglish (US)
Title of host publicationThe Molecular Basis of Human Cancer
PublisherSpringer New York
Pages197-202
Number of pages6
ISBN (Electronic)9781597454582
ISBN (Print)9781934115183
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Neoplasms
Therapeutics
Growth
Food
Angiogenesis Inducing Agents
Blood Vessels
Endothelial Cells
Cell Proliferation
Apoptosis
Oxygen

Keywords

  • Angiogenesis
  • Cancer progression
  • Growth factors
  • Novel cancer therapies
  • Receptor tyrosine kinases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Willis, M., & Klauber-DeMore, N. (2016). Novel cancer therapies targeting angiogenesis. In The Molecular Basis of Human Cancer (pp. 197-202). Springer New York. https://doi.org/10.1007/978-1-59745-458-2_11

Novel cancer therapies targeting angiogenesis. / Willis, Monte; Klauber-DeMore, Nancy.

The Molecular Basis of Human Cancer. Springer New York, 2016. p. 197-202.

Research output: Chapter in Book/Report/Conference proceedingChapter

Willis, M & Klauber-DeMore, N 2016, Novel cancer therapies targeting angiogenesis. in The Molecular Basis of Human Cancer. Springer New York, pp. 197-202. https://doi.org/10.1007/978-1-59745-458-2_11
Willis M, Klauber-DeMore N. Novel cancer therapies targeting angiogenesis. In The Molecular Basis of Human Cancer. Springer New York. 2016. p. 197-202 https://doi.org/10.1007/978-1-59745-458-2_11
Willis, Monte ; Klauber-DeMore, Nancy. / Novel cancer therapies targeting angiogenesis. The Molecular Basis of Human Cancer. Springer New York, 2016. pp. 197-202
@inbook{3250dd3c88a3409198ef0bd1a8630146,
title = "Novel cancer therapies targeting angiogenesis",
abstract = "Cancer growth is generally restricted to tissue that is approximately 2 mm in diameter. At this size, the cancer receives enough oxygen and nutrients by diffusion from nearby blood vessels to survive. Upon further growth, the proliferation of cells within the cancer is matched by the induction of apoptosis due to nutrient deprivation, resulting in a steady-state size. The way cancers adapt to these physical limits is by obtaining their own new blood supply. Only through the induction of its own blood supply, generally by the process of angiogenesis, can cancers exceed the 2 mm size limit and can continue to grow virtually unchecked. Cancer cells stimulate angiogenesis by secreting soluble factors that stimulate vessel growth and/or by suppressing factors that prevent angiogenesis. These factors act primarily upon endothelial cells to promote their proliferation and migration, resulting in the sprouting and formation of tubes, which then develop into vessels.",
keywords = "Angiogenesis, Cancer progression, Growth factors, Novel cancer therapies, Receptor tyrosine kinases",
author = "Monte Willis and Nancy Klauber-DeMore",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-1-59745-458-2_11",
language = "English (US)",
isbn = "9781934115183",
pages = "197--202",
booktitle = "The Molecular Basis of Human Cancer",
publisher = "Springer New York",

}

TY - CHAP

T1 - Novel cancer therapies targeting angiogenesis

AU - Willis, Monte

AU - Klauber-DeMore, Nancy

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Cancer growth is generally restricted to tissue that is approximately 2 mm in diameter. At this size, the cancer receives enough oxygen and nutrients by diffusion from nearby blood vessels to survive. Upon further growth, the proliferation of cells within the cancer is matched by the induction of apoptosis due to nutrient deprivation, resulting in a steady-state size. The way cancers adapt to these physical limits is by obtaining their own new blood supply. Only through the induction of its own blood supply, generally by the process of angiogenesis, can cancers exceed the 2 mm size limit and can continue to grow virtually unchecked. Cancer cells stimulate angiogenesis by secreting soluble factors that stimulate vessel growth and/or by suppressing factors that prevent angiogenesis. These factors act primarily upon endothelial cells to promote their proliferation and migration, resulting in the sprouting and formation of tubes, which then develop into vessels.

AB - Cancer growth is generally restricted to tissue that is approximately 2 mm in diameter. At this size, the cancer receives enough oxygen and nutrients by diffusion from nearby blood vessels to survive. Upon further growth, the proliferation of cells within the cancer is matched by the induction of apoptosis due to nutrient deprivation, resulting in a steady-state size. The way cancers adapt to these physical limits is by obtaining their own new blood supply. Only through the induction of its own blood supply, generally by the process of angiogenesis, can cancers exceed the 2 mm size limit and can continue to grow virtually unchecked. Cancer cells stimulate angiogenesis by secreting soluble factors that stimulate vessel growth and/or by suppressing factors that prevent angiogenesis. These factors act primarily upon endothelial cells to promote their proliferation and migration, resulting in the sprouting and formation of tubes, which then develop into vessels.

KW - Angiogenesis

KW - Cancer progression

KW - Growth factors

KW - Novel cancer therapies

KW - Receptor tyrosine kinases

UR - http://www.scopus.com/inward/record.url?scp=85018927379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018927379&partnerID=8YFLogxK

U2 - 10.1007/978-1-59745-458-2_11

DO - 10.1007/978-1-59745-458-2_11

M3 - Chapter

AN - SCOPUS:85018927379

SN - 9781934115183

SP - 197

EP - 202

BT - The Molecular Basis of Human Cancer

PB - Springer New York

ER -